A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin ...
In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 ...
High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.
In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.
For people who have recovered from diagnoses characterized by persistent fatigue, a new understanding of symptoms seems to have been key to recovery. This is the conclusion of a study from Linköping ...
Mass General Brigham study results signal a call to do further research into the connection between vitamin D supplementation and long COVIDIn a ...
Telemedicine has become a permanent part of healthcare after COVID, though gaps in age, race, and digital access still shape who uses it.
The World Health Organization (WHO) is warning that the war in Iran is worsening public health conditions across the Middle East region. After 10 days of bombings and conflict in Iran, national health ...
Researchers say we must stop treating physical inactivity as a personal failure and fix our broken systems instead.
A University of Calgary–led research team finds that only 7% of children infected with Shiga toxin–producing Escherichia coli (STEC) developed hemolytic uremic syndrome (HUS) during a 395-case ...
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
Six years after the COVID-19 pandemic began, doctors are still treating long COVID patients with complex symptoms and unknown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results